Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire L Mitchell

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Medical Genetics|January 27, 2019
Prevalence of germline pathogenic <i>BRCA1/2</i> variants in sequential epithelial ovarian cancer casesRobert D Morgan, George J Burghel, Nicola Flaum, et al.
Cancers|February 11, 2023
Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?Robert D Morgan, George J Burghel, Nicola Flaum, et al.
British Journal of Cancer|March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?Robert D Morgan, George J Burghel, Nicola Flaum, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2009
Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumorsJames P B O'Connor, Josephine H Naish, Geoff J M Parker, et al.
European Journal of Human Genetics : EJHG|July 12, 2020
Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of EnglandNicola Flaum, Robert D Morgan, George J Burghel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II TrialRobert D Morgan, Andrew R Clamp, Daniel J White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imagingJames P B O'Connor, Richard A D Carano, Andrew R Clamp, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medical Genetics|January 27, 2019
Prevalence of germline pathogenic <i>BRCA1/2</i> variants in sequential epithelial ovarian cancer casesRobert D Morgan, George J Burghel, Nicola Flaum, et al.
Cancers|February 11, 2023
Is Reflex Germline <i>BRCA1/2</i> Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?Robert D Morgan, George J Burghel, Nicola Flaum, et al.
British Journal of Cancer|March 9, 2022
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?Robert D Morgan, George J Burghel, Nicola Flaum, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2009
Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumorsJames P B O'Connor, Josephine H Naish, Geoff J M Parker, et al.
European Journal of Human Genetics : EJHG|July 12, 2020
Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of EnglandNicola Flaum, Robert D Morgan, George J Burghel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II TrialRobert D Morgan, Andrew R Clamp, Daniel J White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imagingJames P B O'Connor, Richard A D Carano, Andrew R Clamp, et al.
Pageof 2